Wednesday, July 23, 2008
The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy
AbstractObjectives To assess the cardiovascular safety, tolerability and efficacy of high doses of granisetron for the treatment of nausea and vomiting in patients undergoing highly emetogenic chemotherapy.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment